Ironwood Pharmaceuticals | IRWD - Trade Debtors


Ironwood Pharmaceuticals reported $81.89M in Trade Debtors for its fiscal quarter ending in December of 2024.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Akebia Therapeutics USD 61.54M 27.17M Mar/2025
Almirall EUR 175.93M 17.87M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amarin USD 127.31M 8.18M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Astellas Pharma JPY 810.23B 75.43B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Charles River Laboratories USD 1.43B 54.59M Dec/2025
Coherus Biosciences USD 62.44M 59.9M Mar/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 60.36M 5.75M Jun/2024
Exact Sciences USD 306.05M 47.28M Sep/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
Karyopharm Therapeutics USD 31.78M 6.82M Sep/2024
Lexicon Pharmaceuticals USD 2.62M 1.09M Jun/2024
MacroGenics USD 69.23M 56.7M Sep/2025
Moderna USD 184M 862M Dec/2025
Myriad Genetics USD 118M 19M Sep/2025
Pacira USD 115.27M 901K Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Takeda JPY 757.92B 55.68B Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024